|
Vectura Signs Up US Partner For VR315 Lung Drug
NASDAQ LN) said Wednesday it has signed a US licensing deal for its generic asthma medicine VR315 with an unnamed "leading international pharmaceutical company." VR315, a drug that industry observers say is a copycat version of GlaxoSmithKline PLC's (GSK. … Vectura signs US license agreement for VR315 product Vectura gets new US partner for copy of lung drug US deal for Vectura; takeover bid for AMAG |
View full post on asthma – Google News